On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction

Statistics and Probability Letters

Volumn 81, Issue 7, 2011, Pages 759-766

  Mertens, B J A ^a   van der Burgt, Y E M ^a   Velstra, B ^a   Mesker, W E ^a   Tollenaar, R A E M ^a   Deelder, A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Classification; Clinical mass spectrometry proteomics; Double cross validation; Model combination; Predictive data fusion

Indexed keywords

EID: 79955127408     PISSN: 01677152     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spl.2011.02.037     Document Type: Article

References (21)

1. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
2. Alagaratnam S., Mertens B.J., Dalebout J.C., Deelder A.M., van Ommen G.J., den Dunnen J.T., et al. Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 2008, 8(8):1552-1563.
3. Barrett, J.H., Cairns, D., 2009. Random Forest classification and variable importance measures based on proteomic profiles from mass spectrometry. In: ISI World Statistics Congress Proceedings, 57th Session.
4. Breiman L. Stacked regressions. Machine Learning 1996, 24:49-64.
5. Breiman L. Random forests. Machine Learning 2001, 45:5-32.
6. Website describing the Random Forest package at http://oz.berkeley.edu/users/breiman/RandomForests/.
7. Cox D.R. Two further applications of a model for binary regression. Biometrika 1958, 45:562-565.
8. The R project on statistical computing. http://www.r-project.org/.
9. Datta S, Pihur V., Datta S. An adaptive optimal ensemble classifier via bagging and rank aggregation with applications to high dimensional data. BMC Bioinformatics 2010, 11:427.
10. Hand D.J. Construction and Assessment of Classification Rules 1997, Wiley, Chichester.
11. Hand D.J. Classifier technology and the illusion of progress (with discussion). Statistical Science 2006, 21:1-34.
12. Matlab, version 7.10. 2010. The MathWorks, Inc..
13. Mertens B.J.A. Exact principal component influence measures applied to the analysis of spectroscopic data on rice. Applied Statistics 1998, 47(4):527-542.
14. Mertens B.J.A. Downdating: interdisciplinary research between statistics and computing. Statistica Neerlandica 2001, 55(3):358-366.
15. Competition on clinical mass spectrometry based proteomic diagnosis. Statistical Applications in Genetics and Molecular Biology 2008, 7:2.
16. Mertens B.J.A., De Noo M.E., Tollenaar R.A.E.M., Deelder A.M. Mass spectrometry proteomic diagnosis: enacting the double cross-validatory paradigm. Journal of Computational Biology 2006, 13(9):1591-1605.
17. Nicolardi S., Palmblad M., Dalebout H., Bladergroen M., Tollenaar R.A.E.M., Deelder A.M., et al. Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling. J. Am. Soc. Mass Spectrom. 2010, (21):1515-1525.
18. de Noo M.E., Deelder A.M., Mertens B.J.A., Ozalp A., Bladergroen M.R., van der Werff M.P.J., et al. Detection of colorectal cancer using MALDI-TOF serum protein profiling. European Journal of Cancer 2005, 42:1068-1076.
19. Stone M. Cross-validatory choice and assessment of statistical predictions (with discussion). Journal of the Royal Statistical Society 1974, 36:111-147.
20. Villanueva J., Philip J., Entenberg D., Chaparro C.A., Tanwar M.K., Holland E.C., et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Analytical Chemistry 2004, 76:1560-1570.
21. Wolpert D.H. Stacked generalization. Neural Networks 1992, 5:241-259.